253 related articles for article (PubMed ID: 32817181)
1. Association of serum neurofilament light and disease severity in patients with spinocerebellar ataxia type 3.
Peng Y; Zhang Y; Chen Z; Peng H; Wan N; Zhang J; Tang J; Wang P; Xie Y; Cai Q; Liu S; Zhang X; Wang C; Yuan H; Li T; Wan L; Shi Y; Qiu R; Klockgether T; Tang B; Liao W; Jiang H
Neurology; 2020 Dec; 95(22):e2977-e2987. PubMed ID: 32817181
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
[TBL] [Abstract][Full Text] [Related]
3. Association Between Serum Neurofilament Light Chain and Neurochemistry Deficits in Patients with Spinocerebellar Ataxia Type 3.
Chen Y; Jin Y; Hu Z; Qiu M; Li D; Cai Q; Tao C; Lou D; Qi L; Chen S; Yu H; Gao Z
Cerebellum; 2024 Feb; 23(1):92-100. PubMed ID: 36598718
[TBL] [Abstract][Full Text] [Related]
4. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
5. Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.
Garcia-Moreno H; Prudencio M; Thomas-Black G; Solanky N; Jansen-West KR; Hanna Al-Shaikh R; Heslegrave A; Zetterberg H; Santana MM; Pereira de Almeida L; Vasconcelos-Ferreira A; Januário C; Infante J; Faber J; Klockgether T; Reetz K; Raposo M; Ferreira AF; Lima M; Schöls L; Synofzik M; Hübener-Schmid J; Puschmann A; Gorcenco S; Wszolek ZK; Petrucelli L; Giunti P
Eur J Neurol; 2022 Aug; 29(8):2439-2452. PubMed ID: 35478426
[TBL] [Abstract][Full Text] [Related]
6. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.
Jakimovski D; Kuhle J; Ramanathan M; Barro C; Tomic D; Hagemeier J; Kropshofer H; Bergsland N; Leppert D; Dwyer MG; Michalak Z; Benedict RHB; Weinstock-Guttman B; Zivadinov R
Ann Clin Transl Neurol; 2019 Sep; 6(9):1757-1770. PubMed ID: 31437387
[TBL] [Abstract][Full Text] [Related]
7. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.
Wilke C; Mengel D; Schöls L; Hengel H; Rakowicz M; Klockgether T; Durr A; Filla A; Melegh B; Schüle R; Reetz K; Jacobi H; Synofzik M
Neurology; 2022 May; 98(20):e1985-e1996. PubMed ID: 35264424
[TBL] [Abstract][Full Text] [Related]
8. Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.
Cajanus A; Katisko K; Kontkanen A; Jääskeläinen O; Hartikainen P; Haapasalo A; Herukka SK; Vanninen R; Solje E; Hall A; Remes AM
Ann Clin Transl Neurol; 2020 Jun; 7(6):903-910. PubMed ID: 32441885
[TBL] [Abstract][Full Text] [Related]
9. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease.
Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B
Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555
[TBL] [Abstract][Full Text] [Related]
10. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice.
Wilke C; Haas E; Reetz K; Faber J; Garcia-Moreno H; Santana MM; van de Warrenburg B; Hengel H; Lima M; Filla A; Durr A; Melegh B; Masciullo M; Infante J; Giunti P; Neumann M; de Vries J; Pereira de Almeida L; Rakowicz M; Jacobi H; Schüle R; Kaeser SA; Kuhle J; Klockgether T; Schöls L; ; Barro C; Hübener-Schmid J; Synofzik M
EMBO Mol Med; 2020 Jul; 12(7):e11803. PubMed ID: 32510847
[TBL] [Abstract][Full Text] [Related]
11. Dystonia in Machado-Joseph disease: Clinical profile, therapy and anatomical basis.
Nunes MB; Martinez AR; Rezende TJ; Friedman JH; Lopes-Cendes I; D'Abreu A; França MC
Parkinsonism Relat Disord; 2015 Dec; 21(12):1441-7. PubMed ID: 26552869
[TBL] [Abstract][Full Text] [Related]
12. Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke.
Onatsu J; Vanninen R; Jäkälä P; Mustonen P; Pulkki K; Korhonen M; Hedman M; Zetterberg H; Blennow K; Höglund K; Herukka SK; Taina M
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2242-2249. PubMed ID: 31151840
[TBL] [Abstract][Full Text] [Related]
13. Age is an important independent modifier of SCA3 phenotype severity.
Jiao S; Wang P; Chen Z; Wang C; Shi Y; Qiu R; Tang B; Jiang H
Neurosci Lett; 2021 Jan; 741():135510. PubMed ID: 33221475
[TBL] [Abstract][Full Text] [Related]
14. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
da Silva Carvalho G; Saute JA; Haas CB; Torrez VR; Brochier AW; Souza GN; Furtado GV; Gheno T; Russo A; Monte TL; Schumacher-Schuh A; D'Avila R; Donis KC; Castilhos RM; Souza DO; Saraiva-Pereira ML; Torman VL; Camey S; Portela LV; Jardim LB
Cerebellum; 2016 Aug; 15(4):518-25. PubMed ID: 26395908
[TBL] [Abstract][Full Text] [Related]
16. Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
Maggi P; Kuhle J; Schädelin S; van der Meer F; Weigel M; Galbusera R; Mathias A; Lu PJ; Rahmanzadeh R; Benkert P; La Rosa F; Bach Cuadra M; Sati P; Théaudin M; Pot C; van Pesch V; Leppert D; Stadelmann C; Kappos L; Du Pasquier R; Reich DS; Absinta M; Granziera C
Neurology; 2021 Aug; 97(6):e543-e553. PubMed ID: 34088875
[TBL] [Abstract][Full Text] [Related]
17. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions.
Souza GN; Kersting N; Krum-Santos AC; Santos AS; Furtado GV; Pacheco D; Gonçalves TA; Saute JA; Schuler-Faccini L; Mattos EP; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2016 Aug; 90(2):134-40. PubMed ID: 26693702
[TBL] [Abstract][Full Text] [Related]
18. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
[TBL] [Abstract][Full Text] [Related]
19. Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3.
Tezenas du Montcel S; Petit E; Olubajo T; Faber J; Lallemant-Dudek P; Bushara K; Perlman S; Subramony SH; Morgan D; Jackman B; Figueroa KP; Pulst SM; Fauret-Amsellem AL; Dufke C; Paulson HL; Öz G; Klockgether T; Durr A; Ashizawa T;
Neurology; 2023 Apr; 100(17):e1836-e1848. PubMed ID: 36797067
[TBL] [Abstract][Full Text] [Related]
20. Identification of a potential exosomal biomarker in spinocerebellar ataxia Type 3/Machado-Joseph disease.
Hou X; Gong X; Zhang L; Li T; Yuan H; Xie Y; Peng Y; Qiu R; Xia K; Tang B; Jiang H
Epigenomics; 2019 Jul; 11(9):1037-1056. PubMed ID: 31144508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
